Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia

Nephron

Volumn 79, Issue 4, 1998, Pages 430-437

  Heilberg, Ita Pfeferman ^a   Martini, Ligia Araujo ^a   Teixeira, Sergio Henrique ^a   Szejnfeld, Vera Lúcia ^a   Carvalho, Aluisio Barbosa ^a   Lobão, Rosélia ^a   Draibe, Sergio Antonio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bisphosphonate; Etidronate; Hypercalciuria; Nephrolithiasis; Osteopenia; Urinary calcium

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; PHOSPHATE;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE REMODELING; CALCIUM STONE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMUR NECK; HUMAN; IDIOPATHIC HYPERCALCIURIA; LUMBAR SPINE; MALE; MORPHOMETRICS; NEPHROLITHIASIS; OSTEOID; OSTEOPENIA; PRIORITY JOURNAL; SUPPLEMENTATION;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; DIET; ETIDRONIC ACID; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES;

EID: 0031852325     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045089     Document Type: Article

References (10)

1. Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H, Ramos OL, Schor N: Bone disease in calcium stone-forming patients. Clin Nephrol 1994;42:175-182.
2. Alhava EM, Juuti M, Karjalainen P: Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 1976;10:154-156.
3. Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, Esper NE, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Jeantet MAL, Bouillon R, Sebert JL: Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991;39:1193-1205.
4. Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P: Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 1983;9:32-34.
5. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C: Low bone mass in idiopathic renal stone formers: Magnitude and significance. J Bone Miner Res 1994;9:1525-1532.
6. Lawoyin S, Sismilich S, Browne R, Pak CYC: Bone mineral content in patients with calcium urolithiasis. Metabolism 1979;28:1250-1254.
7. Pacifici R, Rothstein M, Rifas L, Lau KW, Baylink DJ, Avioli LV, Hruska K: Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1991;71:138-145.
8. Weisinger JR: New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone. Kidney Int 1996;49:1507-1518.
9. Zanchetta JR, Rodriguez G, Negri AL, del Valle E, Spivacow R: Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 1996;73:557-560.
10. Ghazali A, Fuentès V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A: Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997;82:32-38.